Braking bad: Novel mechanisms of CTLA-4 inhibition of T cell responses

American Journal of Transplantation

Volumn 14, Issue 12, 2014, Pages 2685-2690

  Krummey, S M ^a   Ford, M L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

basic (laboratory) research; costimulation; immune modulation; immunobiology; immunosuppression; science; signaling; signaling pathways; T cell biology

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN EXPRESSION; CD4+ T LYMPHOCYTE; COINHIBITION; EFFECTOR CELL; HUMAN; IMMUNOREACTIVITY; INHIBITION KINETICS; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; ORGAN TRANSPLANTATION;

ANIMALS; CTLA-4 ANTIGEN; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; ORGAN TRANSPLANTATION; T-LYMPHOCYTES;

EID: 84910668184     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12938     Document Type: Review

References (40)

1. Linsley PS, Nadler SG., The clinical utility of inhibiting CD28-mediated costimulation. Immunol Rev 2009; 229: 307-321.
2. Bour-Jordan H, Esensten JH, Martinez-Llordella M, Penaranda C, Stumpf M, Bluestone JA., Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol Rev 2011; 241: 180-205.
3. Walunas TL, Bakker CY, Bluestone JA., CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541-2550.
4. Krummey SM, Cheeseman JA, Conger JA, et al. High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept. Am J Transplant 2014; 14: 607-614.
5. Teft WA, Kirchhof MG, Madrenas J., A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006; 24: 65-97.
6. Finn PW, He H, Wang Y, et al. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability. J Immunol 1997; 158: 4074-4081.
7. Ouyang W, Beckett O, Ma Q, Paik JH, DePinho RA, Li MO., Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 2010; 11: 618-627.
8. Kerdiles YM, Beisner DR, Tinoco R, et al. Foxo1 links homing, survival of naive T cells by regulating L-selectin, CCR7, interleukin 7 receptor. Nat Immunol 2009; 10: 176-184.
9. Walunas TL, Bluestone JA., CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J Immunol 1998; 160: 3855-3860.
10. Perez VL, Van Parijs L, Biuckians A, Zheng XX, Strom TB, Abbas AK., Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997; 6: 411-417.
11. Chambers CA, Kuhns MS, Egen JG, Allison JP., CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 2001; 19: 565-594.
12. Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA., The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J Immunol 1999; 162: 1947-1951.
13. Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML., Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J Exp Med 1998; 188: 199-204.
14. Ariyan C, Salvalaggio P, Fecteau S, et al. Cutting edge: Transplantation tolerance through enhanced CTLA-4 expression. J Immunol 2003; 171: 5673-5677.
15. Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein DM., CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol 2001; 2: 58-63.
16. Liu D, Krummey SM, Badell IR, et al. 2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses. J Exp Med 2014, 211: 297-311.
17. Zhang T, Fresnay S, Welty E, et al. Selective CD28 blockade attenuates acute, chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner. Am J Transplant 2011; 11: 1599-1609.
18. Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995; 270: 985-988.
19. Bachmann MF, Waterhouse P, Speiser DE, McKall-Faienza K, Mak TW, Ohashi PS., Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J Immunol 1998; 160: 95-100.
20. Sevilla N, Homann D, von Herrath M, et al. Virus-induced diabetes in a transgenic model: Role of cross-reacting viruses, quantitation of effector T cells needed to cause disease. J Virol 2000; 74: 3284-3292.
21. Tai X, Van Laethem F, Pobezinsky L, et al. Basis of CTLA-4 function in regulatory, conventional CD4(+) T cells. Blood 2012; 119: 5155-5163.
22. Corse E, Allison JP., Cutting edge: CTLA-4 on effector T cells inhibits in trans. J Immunol 2012; 189: 1123-1127.
23. Wang CJ, Kenefeck R, Wardzinski L, et al. Cutting edge: Cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells. J Immunol 2012; 189: 1118-1122.
24. Qureshi OS, Zheng Y, Nakamura K, et al. Trans-endocytosis of CD80, CD86: A molecular basis for the cell-extrinsic function of CTLA-4. Science 2011; 332: 600-603.
25. Hainz U, Jurgens B, Heitger A., The role of indoleamine 2,3-dioxygenase in transplantation. Transpl Int 2007; 20: 118-127.
26. Schneider H, Downey J, Smith A, et al. Reversal of the TCR stop signal by CTLA-4. Science 2006; 313: 1972-1975.
27. Zhang N, Schroppel B, Lal G, et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 2009; 30: 458-469.
28. Salomon B, Lenschow DJ, Rhee L, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431-440.
29. Takahashi T, Tagami T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303-310.
30. Read S, Malmstrom V, Powrie F., Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302.
31. Walker LS, Sansom DM., The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immunol 2011; 11: 852-863.
32. Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322: 271-275.
33. Zhang R, Huynh A, Whitcher G, Chang J, Maltzman JS, Turka LA., An obligate cell-intrinsic function for CD28 in Tregs. Clin Invest 2013; 123: 580-593.
34. Zheng Y, Manzotti CN, Burke F, et al. Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3. J Immunol 2008; 181: 1683-1691.
35. Lu Y, Schneider H, Rudd CE., Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal. Blood 2012; 120: 4560-4570.
36. Riella LV, Sayegh MH., T-cell co-stimulatory blockade in transplantation: Two steps forward one step back. Expert Opin Biol Ther 2013; 13: 1557-1568.
37. Burrell BE, Bishop DK., Th17 cells and transplant acceptance. Transplantation 2010; 90: 945-948.
38. Bouguermouh S, Fortin G, Baba N, Rubio M, Sarfati M., CD28 co-stimulation regulates down Th17 development. PLoS ONE 2009; 4: e5087.
39. Krummey SM, Floyd TL, Liu D, Wagener ME, Song M, Ford ML., Candida-elicited murine Th17 cells express high Ctla-4 compared with Th1 cells and are resistant to costimulation blockade. J Immunol 2014; 192: 2495-2504.
40. Ying H, Yang L, Qiao G, et al. Cutting edge: CTLA-4-B7 interaction suppresses Th17 cell differentiation. J Immunol 2010; 185: 1375-1378.